Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Implementation of a supervised outpatient residence to support ambulatory hematopoietic stem cell transplantation: experience from Puebla, México.

Bone marrow transplantation·2026
Same author

Response to Letter Commenting Upon "Transplantation in Low- and Middle-Income Countries: the Mexican Experience".

Transplantation and cellular therapy·2026
Same author

Innovations in Hematopoietic Stem Cell Transplants in Low- and Middle-Income Countries: A Mexican Perspective.

Transplantation and cellular therapy·2026
Same author

Citomegalovirus Serology and Response to Autologous Haematopoietic Stem Cell Transplantation in Persons With Multiple Sclerosis.

Scandinavian journal of immunology·2025
Same author

Predicting the response to hematopoietic stem cell transplantation in persons with multiple sclerosis: the significance of an early positive response.

Bone marrow transplantation·2025
Same author

Dynamics of Hospitalization and Early Mortality in an Outpatient Allogeneic Hematopoietic Cell Transplantation Program.

Transplantation and cellular therapy·2025

Related Experiment Video

Updated: Jul 16, 2026

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
08:31

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Published on: October 17, 2025

Donor cell leukemia: a critical review.

Guillermo J Ruiz-Argüelles1, Alejandro Ruiz-Argüelles, Javier Garcés-Eisele

  • 1Centro de Hematología y Medicina Interna, Clinica Ruiz de Puebla, Puebla, Mexico. gruiz1@clinicaruiz.com

Leukemia & Lymphoma
|February 28, 2007
PubMed
Summary

Donor cell leukemia (DCL) is a rare complication after stem cell transplantation. Further research is needed to understand its true prevalence and underlying causes.

Area of Science:

  • Hematology
  • Oncology
  • Transplantation immunology

Background:

  • Donor cell leukemia (DCL) is a rare but serious complication following allogeneic stem cell transplantation.
  • Cases have been reported across various transplant types including bone marrow, peripheral blood, and cord blood, predominantly after transplantation for leukemia but also for non-malignant conditions.

Purpose of the Study:

  • To review reported cases of DCL to gain insights into leukemogenesis.
  • To discuss proposed pathogenetic mechanisms of DCL.
  • To highlight the need for further research into DCL prevalence and mechanisms.

Main Methods:

  • Literature review of approximately 40 reported cases of DCL.
  • Discussion of proposed etiological mechanisms.

More Related Videos

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
09:01

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

In Ovo Xenografting of Patient-Derived Acute Lymphoblastic Leukemia (ALL) Cells (PDX-ALL)
06:48

In Ovo Xenografting of Patient-Derived Acute Lymphoblastic Leukemia (ALL) Cells (PDX-ALL)

Published on: August 1, 2025

Related Experiment Videos

Last Updated: Jul 16, 2026

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
08:31

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Published on: October 17, 2025

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
09:01

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

In Ovo Xenografting of Patient-Derived Acute Lymphoblastic Leukemia (ALL) Cells (PDX-ALL)
06:48

In Ovo Xenografting of Patient-Derived Acute Lymphoblastic Leukemia (ALL) Cells (PDX-ALL)

Published on: August 1, 2025

Main Results:

  • DCL has been reported following bone marrow, peripheral blood, and cord blood allografts.
  • The actual prevalence of DCL may be underestimated.
  • Most DCL cases occur after leukemia treatment, but some arise after transplantation for non-malignant disorders.

Conclusions:

  • Existing data suggest DCL is an under-recognized complication of stem cell transplantation.
  • Further studies are essential to accurately determine DCL prevalence and elucidate its pathogenesis.